Delivery Order SPE2DB22D3004-SPE2DB26FQ71Z
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract value of $20,313.12. This firm fixed-price delivery order, with completion targeted for September 23, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) valued at $6,733.04 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by October 24, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,658.26 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $10,494.63. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $19,435.63 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $9,728.31. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is due for completion by September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $43,288.13 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on June 6, 2025, with an ultimate completion date of June 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is executed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract constitutes a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ71ZDelivery Order
The Defense Logistics Agency awarded a $48,171.09 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award criteria. The contract calls for performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 24, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company's substantial IDC with DLA positions it as a primary vendor for pharmaceutical products across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialty medical supplies. This delivery order for Jardiance—a diabetes medication—exemplifies the routine supply operations executed under the larger contract vehicle, supporting the sustained pharmaceutical needs of military beneficiaries and healthcare facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.2k | 10/23/25 |